Anika Therapeutics, Inc. - COM (ANIK)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
13.2M
Holdings value Q2 2024
$335M
Value change Q2 2024
-$3.13M
Grand Portfolio weight change Q2 2024
0%
Number of holders
113
Number of buys Q2 2024
48
Number of sells Q2 2024
-59
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 9.49K $234K +$70.5K $24.67 1
2024 Q2 13.2M $335M -$3.13M $25.33 113
2024 Q1 13.4M $340M +$4.32M $25.40 118
2023 Q4 13.3M $300M +$7.01M $22.66 116
2023 Q3 13M $242M -$5.56M $18.63 116
2023 Q2 13.1M $340M +$436K $25.98 116
2023 Q1 13.1M $376M -$1.05M $28.72 119
2022 Q4 13.1M $388M -$23.7M $29.60 124
2022 Q3 13.5M $321M -$1.53M $23.80 114
2022 Q2 13.5M $302M -$733K $22.32 118
2022 Q1 13.6M $341M +$997K $25.11 114
2021 Q4 13.5M $483M +$10.3M $35.83 125
2021 Q3 13.2M $560M -$491K $42.56 128
2021 Q2 13.1M $569M -$4.27M $43.29 133
2021 Q1 13.3M $543M -$15.4M $40.79 145
2020 Q4 13.5M $613M +$244K $45.26 157
2020 Q3 13.6M $481M -$8.43M $35.39 155
2020 Q2 13.8M $520M +$35.1M $37.73 157
2020 Q1 13M $375M -$24M $28.91 159
2019 Q4 13.4M $697M -$12.7M $51.85 188
2019 Q3 13.7M $750M -$18.3M $54.89 191
2019 Q2 14M $570M +$37.4M $40.62 166
2019 Q1 13.3M $403M +$13.8M $30.24 155
2018 Q4 12.8M $429M -$13.5M $33.61 156
2018 Q3 13.1M $554M -$31.4M $42.18 155
2018 Q2 13.9M $446M +$47.5M $32.00 163
2018 Q1 12.4M $616M +$15.3M $49.72 164
2017 Q4 12.4M $670M -$1.45M $53.91 165
2017 Q3 12.4M $719M +$2.64M $58.00 164
2017 Q2 12.4M $610M +$27.4M $49.34 152
2017 Q1 11.9M $515M +$108M $43.44 153
2016 Q4 11M $538M -$5.25M $48.96 153
2016 Q3 10.9M $521M -$21.1M $47.85 159
2016 Q2 11.5M $615M -$30.8M $53.65 158
2016 Q1 12.1M $542M -$12.6M $44.72 161
2015 Q4 13.2M $475M -$1.42M $38.16 151
2015 Q3 12.5M $397M +$11.1M $31.83 136
2015 Q2 12.1M $401M -$15.2M $33.03 136
2015 Q1 12.3M $505M +$17.8M $41.17 157
2014 Q4 11.9M $483M +$36.8M $40.74 160
2014 Q3 11M $405M +$34.1M $36.66 152
2014 Q2 9.99M $463M -$6.56M $46.33 160
2014 Q1 10.2M $417M +$54.1M $41.10 152